1yvf
From Proteopedia
(New page: 200px<br /><applet load="1yvf" size="450" color="white" frame="true" align="right" spinBox="true" caption="1yvf, resolution 2.500Å" /> '''Hepatitis C virus N...) |
|||
| Line 1: | Line 1: | ||
| - | [[Image:1yvf.gif|left|200px]]<br /><applet load="1yvf" size=" | + | [[Image:1yvf.gif|left|200px]]<br /><applet load="1yvf" size="350" color="white" frame="true" align="right" spinBox="true" |
caption="1yvf, resolution 2.500Å" /> | caption="1yvf, resolution 2.500Å" /> | ||
'''Hepatitis C virus NS5B RNA-dependent RNA polymerase complex with inhibitor PHA-00729145'''<br /> | '''Hepatitis C virus NS5B RNA-dependent RNA polymerase complex with inhibitor PHA-00729145'''<br /> | ||
==Overview== | ==Overview== | ||
| - | A novel series of nonnucleoside HCV NS5B polymerase inhibitors were | + | A novel series of nonnucleoside HCV NS5B polymerase inhibitors were prepared from (2Z)-2-(benzoylamino)-3-(5-phenyl-2-furyl)acrylic acid, a high throughput screening lead. SAR studies combined with structure based drug design focusing on the southern heterobiaryl region of the template led to the synthesis of several potent and orally bioavailable lead compounds. X-ray crystallography studies were also performed to understand the interaction of these inhibitors with HCV NS5B polymerase. |
==About this Structure== | ==About this Structure== | ||
| - | 1YVF is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Hepatitis_c_virus Hepatitis c virus] with PO4, CL, PH7 and GOL as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/RNA-directed_RNA_polymerase RNA-directed RNA polymerase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.7.7.48 2.7.7.48] Full crystallographic information is available from [http:// | + | 1YVF is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Hepatitis_c_virus Hepatitis c virus] with <scene name='pdbligand=PO4:'>PO4</scene>, <scene name='pdbligand=CL:'>CL</scene>, <scene name='pdbligand=PH7:'>PH7</scene> and <scene name='pdbligand=GOL:'>GOL</scene> as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/RNA-directed_RNA_polymerase RNA-directed RNA polymerase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.7.7.48 2.7.7.48] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1YVF OCA]. |
==Reference== | ==Reference== | ||
| Line 14: | Line 14: | ||
[[Category: Protein complex]] | [[Category: Protein complex]] | ||
[[Category: RNA-directed RNA polymerase]] | [[Category: RNA-directed RNA polymerase]] | ||
| - | [[Category: Anstadt, R | + | [[Category: Anstadt, R A.]] |
| - | [[Category: Finzel, B | + | [[Category: Finzel, B C.]] |
| - | [[Category: Greene, M | + | [[Category: Greene, M L.]] |
| - | [[Category: Gross, R | + | [[Category: Gross, R J.]] |
| - | [[Category: Harris, M | + | [[Category: Harris, M S.]] |
| - | [[Category: Kilkuskie, R | + | [[Category: Kilkuskie, R E.]] |
| - | [[Category: Kopta, L | + | [[Category: Kopta, L A.]] |
| - | [[Category: Mitchell, M | + | [[Category: Mitchell, M A.]] |
| - | [[Category: Nugent, R | + | [[Category: Nugent, R A.]] |
| - | [[Category: Pfefferkorn, J | + | [[Category: Pfefferkorn, J A.]] |
| - | [[Category: Schwende, F | + | [[Category: Schwende, F J.]] |
| - | [[Category: Shelly, J | + | [[Category: Shelly, J A.]] |
| - | [[Category: Wells, P | + | [[Category: Wells, P A.]] |
[[Category: CL]] | [[Category: CL]] | ||
[[Category: GOL]] | [[Category: GOL]] | ||
| Line 38: | Line 38: | ||
[[Category: thumb]] | [[Category: thumb]] | ||
| - | ''Page seeded by [http:// | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 16:09:31 2008'' |
Revision as of 14:09, 21 February 2008
|
Hepatitis C virus NS5B RNA-dependent RNA polymerase complex with inhibitor PHA-00729145
Overview
A novel series of nonnucleoside HCV NS5B polymerase inhibitors were prepared from (2Z)-2-(benzoylamino)-3-(5-phenyl-2-furyl)acrylic acid, a high throughput screening lead. SAR studies combined with structure based drug design focusing on the southern heterobiaryl region of the template led to the synthesis of several potent and orally bioavailable lead compounds. X-ray crystallography studies were also performed to understand the interaction of these inhibitors with HCV NS5B polymerase.
About this Structure
1YVF is a Protein complex structure of sequences from Hepatitis c virus with , , and as ligands. Active as RNA-directed RNA polymerase, with EC number 2.7.7.48 Full crystallographic information is available from OCA.
Reference
Inhibitors of HCV NS5B polymerase. Part 1: Evaluation of the southern region of (2Z)-2-(benzoylamino)-3-(5-phenyl-2-furyl)acrylic acid., Pfefferkorn JA, Greene ML, Nugent RA, Gross RJ, Mitchell MA, Finzel BC, Harris MS, Wells PA, Shelly JA, Anstadt RA, Kilkuskie RE, Kopta LA, Schwende FJ, Bioorg Med Chem Lett. 2005 May 16;15(10):2481-6. PMID:15863301
Page seeded by OCA on Thu Feb 21 16:09:31 2008
Categories: Hepatitis c virus | Protein complex | RNA-directed RNA polymerase | Anstadt, R A. | Finzel, B C. | Greene, M L. | Gross, R J. | Harris, M S. | Kilkuskie, R E. | Kopta, L A. | Mitchell, M A. | Nugent, R A. | Pfefferkorn, J A. | Schwende, F J. | Shelly, J A. | Wells, P A. | CL | GOL | PH7 | PO4 | Fingers | Hcv | Ns5b | Palm | Polymerase | Thumb
